BACKGROUND: Aspiration pneumonia is a leading cause of death in people with Parkinson disease (PD). Th e pathogenesis of these infections is largely attributed to the presence of dysphagia with silent aspiration or aspiration without an appropriate cough response. Th e goal of this study was to test refl ex cough thresholds and associated urge-to-cough (UTC) ratings in participants with PD with and without dysphagia.
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Aspiration pneumonia is a leading cause of death in people with idiopathic Parkinson disease (PD). [1] [2] [3] Although the pathogenesis of these infections is largely attributed to the presence of silent aspiration (aspiration without a reflex cough response), we know relatively little about reflex cough in PD. One important aspect of reflex cough is the urge to cough (UTC), a respiratory sensation that precedes the reflex cough. The UTC for induced reflex cough increases in a log-log linear fashion with increasing magnitude of a cough (tussigenic) stimulus. [4] [5] [6] [7] People with a history of aspiration pneumonia have comparable reflex cough thresholds to age-matched control subjects but demonstrate a blunted UTC at subthreshold levels of a tussigenic stimulus. 8 Although the literature suggests that both dysphagia and dystussia coexist in PD, 9 ,10 few studies have tested refl ex cough in PD, [11] [12] [13] and no studies have examined the relationship of refl ex cough responses to swallowing ability. Leow and colleagues 13 observed that the cough sensory threshold was not diff erent for people with PD vs agematched control subjects; however, Fontana et al 11 found slightly higher thresholds for people with PD. Neither of these studies included a metric for UTC or account for the infl uence of swallowing function on refl ex cough outcomes. Th e goal of the present study was to test refl ex cough thresholds and UTC ratings in participants with PD with and without dysphagia. We hypothesized that worsening dysphagia severity would result in signifi cantly higher cough thresholds and reduced UTC ratings.
Materials and Methods
Th is prospective study included 20 participants with mild to moderate PD. Participants were recruited from the University of Florida Center for Movement Disorders and Neurorestoration by consecutive referral to speech-language pathology over a 3-month period. Fellowshiptrained movement disorders neurologists diagnosed PD using UK brain bank criteria. 14 Th is study received ethical approval by the University of Florida Institutional Review Board (188-2012). All participants provided written informed consent prior to the initiation of any study procedures. Th ey were tested within the window of optimized medication function (ie, 1 h aft er taking anti-PD medications). Inclusion criteria were (1) diagnosis of idiopathic PD, (2) Hoehn and Yahr (H&Y) stages II to IV, and (3) age 45 to 85 years. Exclusion criteria were (1) history of other neurologic disorders; (2) history of head, neck, or lung cancer; (3) history of chronic respiratory disorders/diseases; (4) smoking in the past 5 years; (5) uncontrolled hypertension; (6) minimental status examination score of at least 24; and (7) failed pulmonary function screening test (ie, FEV 1 /FVC , 75%).
Cough Testing
Participants were outfi tted with a face mask covering the nose and mouth. Th e face mask was coupled to a pneumotachograph and differential pressure transducer and had a side port with a one-way inspiratory valve for nebulizer connection. Th e nebulizer was a DeVilbiss T-piece (DeVilbiss Healthcare LLC) connected to a dosimeter that delivered an aerosolized solution during inspiration (delivery duration, 2 s). Participants completed a capsaicin challenge with three randomized blocks of 0, 50, 100, and 200 m M capsaicin. Th e capsaicin was dissolved in a vehicle solution of 80% physiologic saline and 20% ethanol. Th e maximum concentration of 200 m M has been identifi ed as a suprathreshold concentration for eliciting the refl ex cough in healthy participants. [15] [16] [17] Th e cough airfl ow signal was recorded by a laptop computer through the PowerLab data acquisition system (ADInstruments Pty Ltd).
Participants were seated comfortably for an initial 30 s of quiet breathing to acclimate to the face mask. Th ey were given the instruction, "Cough if you need to, " prior to capsaicin delivery. Th e solution was automatically administered upon detection of an inspired breath, with a minimum of 1 min between each presentation of capsaicin during which time participants were provided water.
Swallow Testing
Swallowing was assessed by a certifi ed speech-language pathologist. Participants were positioned in the lateral viewing plane while sitting in a chair and self-administered a 3-oz thin-liquid challenge bolus of barium sulfate contrast solution. Images were acquired with a Siemens radiographic/ fl uoroscopic unit (Siemens Corporation) and recorded at 30 frames/s. Th e selected swallowing outcome measure was quantifi ed with the penetrationaspiration scale (P-A), 18 a valid and ordinal eight-point assessment.
Outcome Measures
Cough Th reshold: Total number of coughs produced in response to 200 m M capsaicin (CrTot ) was counted from the fi rst cough epoch (defined as an initial cough and the subsequent cough reaccelerations following one inspiration) with each presentation of capsaicin. These measures were made from the recorded cough airflow signals. The concentration of capsaicin that elicited the reliable two-cough response (Cr2) was recorded and identified as the cough threshold. A reliable Cr2 was defined as at least two coughs produced within 30 s following presentation of the stimulus in two of three trials of that concentration.
Urge to Cough:
Following each capsaicin trial, participants rated their UTC on a modifi ed Borg rating scale of 0 to 10, where 0 was no UTC and 10 was maximal UTC. Th e median UTC ratings were plotted against capsaicin concentration on a log-log scale, and a linear regression line was used to fi t the data. Th e slope of the line was used as a measure of UTC sensitivity to capsaicin and was compared in participants with and without (P-A score Յ 2) dysphagia.
Statistical Analysis
Descriptive statistics were used to summarize the data. Spearman r correlations and regression analyses were used to assess the infl uence of PD severity (H&Y score), age, sex, disease duration, and dysphagia severity (P-A score) on UTC and CrTot. Sex, H&Y score, disease duration, and age were entered into the fi rst step of the stepwise hierarchical regression model, with UTC or CrTot as the dependent variables. P-A score was entered in the second step to assess its contribution to the dependent variables above and beyond other person-and PD-specifi c factors. Diff erences in age and disease severity between participants with and without dysphagia were compared by Mann-Whitney U tests. Th e signifi cance criterion was set at P , .05.
Results
Twenty participants (14 men), aged 49 to 81 years (average, 68 years) completed this study. Disease severity spanned from H&Y stage II to IV with Unifi ed Parkinson's Disease Rating Scale on medication scores between 9 and 48 (average, 24.4). Disease severity was not signifi cantly associated with swallowing dysfunction (P-A score) ( r s 5 0.091, P 5 .704). None of the participants had a history of aspiration pneumonia. Demographic information is included in Table 1 .
Cough Threshold
All participants without dysphagia had a reliable Cr2 to 200 m M capsaicin compared with only 50% of participants with dysphagia. Th erefore, true cough thresholds could not be established for all participants. Regression analysis revealed that one factor, P-A score ( b 5
Urge to Cough
Regression analysis revealed that one factor, P-A score ( b 5 2 0.593, P 5 .017), explained 27.6% of the variance in UTC [ R 2 
More specifi cally, as the P-A score (dysphagia severity) increased, UTC at 200 m M capsaicin decreased.
Th e slope of the log-log linear line of best fi t was 0.37 for the dysphagic group and 0.64 for the nondysphagic group ( Fig 1 ) . Five participants were scored as nondysphagic (P-A score Յ 2), and 15 were scored as dysphagic. No signifi cant diff erences in age ( P 5
Discussion
Aspiration pneumonia is a leading cause of death in PD, [1] [2] [3] and although the pathogenesis of this infection is not completely understood, it is likely attributable to dysphagia and concomitant dystussia. Although our current clinical management focuses on rehabilitation of dysphagia with relative disregard for concomitant dystussia, our understanding of airway protection is evolving to include a continuum of behaviors serving to prevent (swallowing) and eject material from the airway (coughing). To our knowledge, the current study is the fi rst of refl ex cough sensitivity and UTC in people with PD with and without known dysphagia. Th e results of this study support the hypothesis that both swallowing and cough function should be considered in the management of airway protection dysfunction in PD.
Dysphagia oft en is considered an inevitable consequence of PD. Dystussia has also been identifi ed in PD, 9-13 but has garnered less clinical research interest until recently. Pitts and colleagues 9, 10 found that voluntary cough expiratory airfl ow parameters are signifi cantly decreased for people with PD that penetrated and/or aspirated . No studies have tested the relationship between refl ex cough and swallowing function in PD. Th e behaviors of refl ex cough and swallowing are similar in that they are both sensorimotor functions initiated by a specifi c oropharyngeal or laryngeal stimulus. In the case of swallowing, a specifi c bolus triggers the oropharyngeal swallow. In the case of refl ex cough, the tussigenic stimulus, oft en aspirate material, induces the cough. Th erefore, refl ex cough (as opposed to voluntary cough) should better assist in elucidating the pathogenesis of aspiration pneumonia in PD given the high ecologic validity of the behavior.
Fontana et al 11 studied refl ex cough in PD by using ultrasonically nebulized distilled water as the coughinducing stimulus. Th ey found a trend toward higher refl ex cough thresholds in PD. Ebihara and colleagues 12 then studied refl ex cough in female participants with early PD and advanced PD and age-matched control participants by using citric acid to induce cough. Th ey found that participants with advanced stage PD had higher cough thresholds than early stage PD and control participants. However, there was no signifi cant diff erence in cough thresholds between early stage and control participants. Leow and colleagues 13 studied refl ex cough thresholds in participants with PD and healthy older adults and found no signifi cant diff erences in cough thresholds across groups. Regression and correlation analyses from the current study revealed no relationship between disease severity and cough or swallowing outcomes, consistent with the results from the aforementioned studies. Interestingly, none of the studies of refl ex cough in PD identifi ed whether participants had dysphagia. It is possible that the presence of dysphagia may have better diff erentiated the groups, a hypothesis the current study fi ndings support.
We found signifi cant diff erences in the primary cough outcomes as a function of dysphagia severity. We chose 200 m M capsaicin as the highest concentration because it had been identifi ed as a suprathreshold dose in previous studies. [15] [16] [17] We were surprised to fi nd that only 50% of the total sample had a reliable Cr2 to 200 m M capsaicin. Further inspection of the data revealed that all participants without dysphagia had a reliable Cr2, but only 33% of the participants with dysphagia had a reliable Cr2. In the future, 500 m M capsaicin will be included in our capsaicin cough challenge to more reliably establish a cough threshold for all participants.
In addition to absolute refl ex cough thresholds, it is important to understand participants' perceived sensation to threshold and subthreshold cough stimuli. Th e UTC is a respiratory sensation that precedes the cough motor response. [5] [6] [7] Th e urge, as the fi rst component of the cognitive motivational system, brings the cough behavior to consciousness and, thus, allows for modulation of behavior. 7 More specifi cally, the UTC requires discriminative and aff ective processing. 4, 19, 20 Discriminative processing includes assessment of the characteristics of the cough stimulus, whereas the aff ective processing assigns emotional salience to the stimulus. 4, 19, 20 In healthy control subjects, UTC is directly related to the intensity of the cough stimulus, resulting in a log-log linear relationship between capsaicin concentration and UTC. [4] [5] [6] [7] To our knowledge, this study is the fi rst to examine UTC and the relationship among cough sensory threshold, UTC, and swallowing in a cohort of participants with PD. One study investigated the UTC and refl ex cough thresholds elicited with citric acid in participants with a history of aspiration pneumonia compared with age-matched control participants. 8 Results revealed that Cr2 and the fi ve-cough response (Cr5) were significantly higher for participants with a history of aspiration pneumonia. Th ere was no signifi cant diff erence in UTC ratings between groups at Cr2 or Cr5, but there were signifi cant diff erences in UTCs between groups at one-half the Cr2 and Cr5 concentrations, demonstrating a blunting of UTC at subthreshold doses of citric acid for people with a history of aspiration pneumonia. We, therefore, hypothesized that the participants with dysphagia would have signifi cantly reduced UTCs, specifi cally at subthreshold levels of capsaicin, which the results of this study support. In this case, participants with dysphagia showed a blunting of UTC at subthreshold stimuli compared with those without dysphagia. Th e slope of the log-log linear line of best fi t was 0.37 for the dysphagic group and 0.64 for the nondysphagic group.
In fact, both groups demonstrated a reduced UTC sensitivity compared with other healthy populations in which the UTC sensitivity (slope) has been closer to 2 . 16 Th e current study is not without limitations. Future studies should recruit larger numbers of participants to better assess other individual factors that might infl uence UTC and cough-related fi ndings. Additionally, a tussigenic stimulus that is more similar to aspirate material and, therefore, more ecologically valid should be considered. Capsaicin was selected based on multiple studies having identifi ed the stimulus as safe, reproducible, and measureable. 21 In contrast to citric acid, capsaicin can be presented in succession with consistent, reliable results within one session and across sessions. 22 Fog, or nebulized distilled water, is another tussigenic agent that has been used in cough research, but no studies have investigated UTC in relation to fog.
Conclusions
Th e results of this study add to the body of literature, suggesting that various components of the cough behavior are impaired in people with PD, particularly in those with dysphagia. Th is study highlights the idea that the absent cough response in people with silent aspiration should not be considered as solely secondary to increased cough thresholds; it may also be due to a reduced UTC in response to a specifi c stimulus. Th erefore, a reduced awareness of the presence of a tussigenic stimulus and a reduced response when the stimulus is perceived are possible. Th ese factors likely combine to place patients at risk for uncompensated aspiration (silent aspiration), ultimately allowing the aspirated material to remain in the respiratory tract and serve as a focal point for infection.
Improvement in long-term airway protection in PD likely will require behavioral therapy targeting cough dysfunction. Th e UTC may be one of the most viable targets for cough rehabilitation given that the literature suggests that it can be behaviorally modulated. 23 To identify the best ways to upregulate the UTC, we must better understand the factors resulting in decreased UTC in PD. Th erefore, future studies should focus on identifying the discriminative and aff ective components of UTC. Uncovering these issues could reveal specifi c therapeutic targets for the behavioral treatment of dysfunctional cough in PD.
